Plasma fibrinogen: a sensitive biomarker for the screening of periprosthetic joint infection in patients undergoing re-revision arthroplasty.

Hong XuLi LiuJin-Wei Xie Qiang Huang Ya-Hao Lai Zong-Ke Zhou

Published in: BMC musculoskeletal disorders (2022)

Plasma fibrinogen is a cost-effective, convenient biomarker that can be used to rule out PJI in patients scheduled for re-revision arthroplasty. In combination with CRP, it may be effective in diagnosing PJI in such patients.

Keyphrases

end stage renal disease
ejection fraction
patients undergoing
newly diagnosed
chronic kidney disease
total knee arthroplasty
patient reported